Design, synthesis, and biological evaluation of potent c-Met inhibitors. 2008

Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
Department of Medicinal Chemistry, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320-1799, USA. dangelo@amgen.com

c-Met is a receptor tyrosine kinase that plays a key role in several cellular processes but has also been found to be overexpressed and mutated in different human cancers. Consequently, targeting this enzyme has become an area of intense research in drug discovery. Our studies began with the design and synthesis of novel pyrimidone 7, which was found to be a potent c-Met inhibitor. Subsequent SAR studies identified 22 as a more potent analog, whereas an X-ray crystal structure of 7 bound to c-Met revealed an unexpected binding conformation. This latter finding led to the development of a new series that featured compounds that were more potent both in vitro and in vivo than 22 and also exhibited different binding conformations to c-Met. Novel c-Met inhibitors have been designed, developed, and found to be potent in vitro and in vivo.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular
D045744 Cell Line, Tumor A cell line derived from cultured tumor cells. Tumor Cell Line,Cell Lines, Tumor,Line, Tumor Cell,Lines, Tumor Cell,Tumor Cell Lines
D047428 Protein Kinase Inhibitors Agents that inhibit PROTEIN KINASES. Protein Kinase Inhibitor,Inhibitor, Protein Kinase,Inhibitors, Protein Kinase,Kinase Inhibitor, Protein,Kinase Inhibitors, Protein
D018360 Crystallography, X-Ray The study of crystal structure using X-RAY DIFFRACTION techniques. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) X-Ray Crystallography,Crystallography, X Ray,Crystallography, Xray,X Ray Crystallography,Xray Crystallography,Crystallographies, X Ray,X Ray Crystallographies
D019859 Proto-Oncogene Proteins c-met Cell surface protein-tyrosine kinase receptors for HEPATOCYTE GROWTH FACTOR. They consist of an extracellular alpha chain which is disulfide-linked to the transmembrane beta chain. The cytoplasmic portion contains the catalytic domain and sites critical for the regulation of kinase activity. Mutations in the c-met proto-oncogene are associated with papillary renal carcinoma and other neoplasia. HGF Receptor,Hepatocyte Growth Factor Receptor,c-met Proteins,met Proto-Oncogene Proteins,MET Proto-Oncogene, Receptor Tyrosine Kinase,MET Receptor Tyrosine Kinase,Receptor, HGF,Receptor, Hepatocyte Growth Factor,Receptor, Scatter Factor,Scatter Factor Receptor,c-Met Receptor Tyrosine Kinase,MET Proto Oncogene, Receptor Tyrosine Kinase,Proto Oncogene Proteins c met,Proto-Oncogene Proteins, met,c Met Receptor Tyrosine Kinase,c met Proteins,met Proto Oncogene Proteins
D021241 Spectrometry, Mass, Electrospray Ionization A mass spectrometry technique used for analysis of nonvolatile compounds such as proteins and macromolecules. The technique involves preparing electrically charged droplets from analyte molecules dissolved in solvent. The electrically charged droplets enter a vacuum chamber where the solvent is evaporated. Evaporation of solvent reduces the droplet size, thereby increasing the coulombic repulsion within the droplet. As the charged droplets get smaller, the excess charge within them causes them to disintegrate and release analyte molecules. The volatilized analyte molecules are then analyzed by mass spectrometry. ESI Mass Spectrometry,Electrospray Ionization Mass Spectrometry,Mass Spectrometry, ESI,Spectrometry, ESI Mass

Related Publications

Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
September 2023, Organic & biomolecular chemistry,
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
May 2015, ACS medicinal chemistry letters,
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
December 2020, Bioorganic & medicinal chemistry letters,
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
June 2012, ChemMedChem,
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
January 2024, Molecules (Basel, Switzerland),
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
December 2019, Bioorganic & medicinal chemistry letters,
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
June 2016, Bioorganic & medicinal chemistry letters,
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
September 2016, Bioorganic & medicinal chemistry,
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
January 2012, Organic & biomolecular chemistry,
Noel D D'Angelo, and Steven F Bellon, and Shon K Booker, and Yuan Cheng, and Angela Coxon, and Celia Dominguez, and Ingrid Fellows, and Douglas Hoffman, and Randall Hungate, and Paula Kaplan-Lefko, and Matthew R Lee, and Chun Li, and Longbin Liu, and Elizabeth Rainbeau, and Paul J Reider, and Karen Rex, and Aaron Siegmund, and Yaxiong Sun, and Andrew S Tasker, and Ning Xi, and Shimin Xu, and Yajing Yang, and Yihong Zhang, and Teresa L Burgess, and Isabelle Dussault, and Tae-Seong Kim
November 2013, Bioorganic & medicinal chemistry,
Copied contents to your clipboard!